In the years since the EPA’s “Tier 4” emission standards first hit the heavy equipment world, a secondary market in older “pre-Tier 4” used construction equipment has blossomed. Buying... read more →
Traditionally, biopharma companies can increase their revenue for research and overhead through price increases for exclusively owned products. (First, raise the price on drugs you’ve got a patent for.... read more →
When it comes to budgeting your expenses for the next year, many operations managers start with the direct labor and material costs. That is, how much it costs to... read more →
The biopharma industry is one in which successful companies, investors, drug developers, and scientists can manage – even celebrate – the inevitable failures of research and development. In a... read more →
By now, you’ll have read the Institute for Supply Management’s August 2019 manufacturing report on business. The headline? The ISM Manufacturing Index has fallen below 50%. After months of... read more →